Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (764458)
Received: 23 November 2020
Accepted: 17 May 2021
First Online: 27 May 2021
: The study was conducted at the University Hospital Leuven, Belgium, and approved by the local Ethics Committee (University Hospitals Leuven/KU Leuven, ClinicalTrials.gov no. NCT02562989). The subjects (or legal representative) gave written informed consent before enrollment in the study.
: All authors consent for publication and all subjects enrolled in the study agreed for their data to be used for further analyses.
: TGL, EDH, CS, and AS are or were employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Kenilworth, NJ USA, at the time of the study and may own stock and/or hold stock options in the Company.